Pseudomonas aeruginosa is one of the leading causes of bacteraemia and pneumonia in patients hospitalized in intensive care units (Bertrand et al., 2001) . In addition to being intrinsically resistant to several antimicrobial agents, P. aeruginosa can acquire resistance to conventional anti-pseudomonal antibiotics including anti-pseudomonal penicillins, ceftazidime, carbapenems, aminoglycosides and ciprofloxacin (Carmeli et al., 1999) . The mechanisms of resistance to b-lactams mostly involve stable upregulation of the intrinsic cephalosporinase AmpC, acquisition of transferable b-lactamases (with narrow or extended spectrum), outer-membrane impermeability (alteration or underproduction of porin OprD) or MexAB-OprF efflux pump overproduction (Livermore, 2002) . Clinical P. aeruginosa isolates producing class A extended-spectrum b-lactamases (ESBLs) such as TEM, SHV, PER, GES, VEB, BEL and CTX-M are frequently described (Weldhagen et al., 2003) . Ambler class B enzymes (metallo-b-lactamases, such as IMP, VIM, SPM and GIM) also spread among clinical P. aeruginosa isolates, especially in Asia and Europe (Rossolini et al., 2007) . P. aeruginosa strains producing extended-spectrum oxacillinases (from the Ambler class D) have sporadically been described but knowledge of their spread in the clinical setting remains poor (Poirel et al., 2010) .
Within the framework of a hospital clinical research project, we found evidence of an outbreak of P. aeruginosa producing the extended-spectrum oxacillinase OXA-19. This report describes the microbiological investigation of this outbreak.
In the bacteriology laboratory of Nancy University Hospital (Lorraine, France), the susceptibility of all P. aeruginosa isolates to An ESBL phenotypic screening test was performed for all Caz R isolates by using the double disc susceptibility test (DDST), where discs of ceftazidime, aztreonam and cefepime (30 mg each) were positioned at a variable distance from a disc containing amoxicillin (20 mg) and clavulanate (10 mg) (Jiang et al., 2006) . A slight synergy was observed for 48 isolates between ceftazidime-and clavulanatecontaining discs only when the distance between discs (centre to centre) was 12 mm (data not shown).
For all of these isolates, isoelectric focusing (Hocquet et al., 2003) revealed the presence of the AmpC cephalosporinase (pI 8.1), as well as a secondary b-lactamase exhibiting a pI of 7.6. The identification of the secondary b-lactamase was carried out by PCR on whole-cell DNA using primers specific for the class D b-lactamases (OXA-10, OXA-2 and OXA-1 derivatives) because of the basic pI of this enzyme and the poor synergy provided by clavulanate toward ceftazidime (Bert et al., 2002) . Only PCR using primers targeting the bla OXA-10 group was positive. As bla OXA genes are most frequently found in class 1 integrons (Fluit & Schmitz, 2004) , we also performed PCR experiments using consensus primers 59-CS and 39-CS specific for class 1 integrons (Levesque et al., 1995) . The PCR amplicons (1673 bp) were sequenced on both strands, resulting in the identification of a class 1 integron (GenBank accession no. FJ906752) containing two resistance gene cassettes, namely aacA4, which determines an aminoglycoside 69-Nacetyltransferase conferring high resistance to gentamicin and tobramycin, and bla , which encodes the extendedspectrum OXA-19 (Mugnier et al., 1998) .
PFGE typing was performed on all Caz R isolates as previously described (Bertrand et al., 2000) . We used the GelCompar software (Applied Maths) to establish a DNA similarity matrix. A dendrogram was constructed using the unweighted pairgroup method with arithmetic averages clustering method and the Dice coefficient. We ensured that the gels were comparable by including Staphylococcus aureus NCTC 8325 as a reference. PFGE results were interpreted according to international recommendations (Tenover et al., 1995) . PFGE analysis showed that the 92 isolates clustered in 10 different PFGE patterns: two large clusters comprising 23 and 14 isolates, respectively; three smaller clusters comprising three, two and three isolates, respectively; and four unique patterns from four isolates (Fig. 1) To our knowledge, this is the first report describing an outbreak involving P. aeruginosa isolates producing a clavulanate-resistant extended-spectrum oxacillinase. During the same period, we also evidenced an outbreak of P.
aeruginosa producing OXA-28 in another French hospital (Hocquet et al., 2008) . The emergence of P. aeruginosa producing such b-lactamases may be related to a recent spread of extended-spectrum oxacillinases among P. aeruginosa clinical isolates. This phenomenon may be underestimated because of the difficulty in detecting such strains in clinical laboratories. Indeed, most of these oxacillinases (with the exception of OXA-18) are poorly inhibited by clavulanate. This undermines DDST Fig. 1 . Pulsed-field electrophoresis banding patterns after DraI digestion of non-duplicate P. aeruginosa isolates.
Correspondence screening tests using conventional distance (¢20 mm) between third-generation cephalosporins and clavulanate. Extendedspectrum oxacillinase activity is also inhibited by cloxacillin, a compound used in phenotypic screening tests to unmask ESBLs in an AmpC overproduction background (Aubert et al., 2004) . OXA-19-producing P. aeruginosa is detected only when ceftazidime-and clavulanatecontaining discs are in close approximation to each other.
In conclusion, the emergence and spread of extended-spectrum oxacillinases among P. aeruginosa clinical strains is a matter of concern. These multidrug-resistant bacteria caused infections that are difficult to treat, as colistin often remains the unique therapeutic option. Ongoing surveillance of these micro-organisms, with the use of a specific screening test, is warranted as well as the implementation of infection control measures to prevent their cross-transmission between patients.
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